Amicus Therapeutics to Showcase Cutting-Edge Medicines for Rare Diseases at Bank of America Health Care Conference

Amicus Therapeutics to Take part in the Bank of America 2024 Health Care Conference

Amicus Therapeutics, Inc. has announced that they will be participating in a fireside chat at the Bank of America 2024 Health Care Conference in Las Vegas, NV on Wednesday, May 15, 2024, at 1:40 p.m. P.T. The live audio webcast of the presentation can be accessed via the investors section of the Amicus Therapeutics corporate website at https://ir.amicusrx.com/events-and-presentations.

Amicus Therapeutics is a global biotechnology company dedicated to discovering, developing, and delivering innovative medicines for people with rare diseases. Their focus is on advancing and expanding a pipeline of cutting-edge medicines for rare diseases, with a strong emphasis on the patient experience. For more information about their work and mission, visit their website at www.amicusrx.com and follow them on X and LinkedIn.

Investors interested in learning more about Amicus Therapeutics can contact Andrew Faughnan, Vice President of Investor Relations at [afaughnan@amicusrx.com](mailto:afaughnan@amicusrx.com) or (609) 662-3809. Media inquiries should be directed to Diana Moore, Head of Global Corporate Affairs and Communications at [dmoore@amicusrx.com](mailto:dmoore@amicusrx.com) or (609) 662-5079 for more information about this event and other news from Amicus Therapeutics

Leave a Reply